Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Johnson & Johnson

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Consumer Health Capital Expenditures

Consumer Health Capital Expenditures % Chg.

Consumer Health Capital Expenditures Common Size

Innovative Medicine Capital Expenditures

Innovative Medicine Capital Expenditures % Chg.

Innovative Medicine Capital Expenditures Common Size

MedTech Capital Expenditures

MedTech Capital Expenditures % Chg.

MedTech Capital Expenditures Common Size

Other Capital Expenditures

Other Capital Expenditures % Chg.

Other Capital Expenditures Common Size

Total Capital Expenditures

Total Capital Expenditures Common Size

Total Capital Expenditures % Chg.

Capital Expenditures

Consumer Health Income Before Tax

Consumer Health Income Before Tax % Chg.

Consumer Health Income Before Tax Common Size

Innovative Medicine Income Before Tax

Innovative Medicine Income Before Tax % Chg.

Innovative Medicine Income Before Tax Common Size

MedTech Income Before Tax

MedTech Income Before Tax % Chg.

MedTech Income Before Tax Common Size

Other EBT

Other EBT % Chg.

Other EBT Common Size

Total EBT

Total EBT Common Size

Total EBT % Chg.

Sales % Change due to Transactions

Sales % Change due to Transactions % Chg.

Sales % Change due to Price

Sales % Change due to Price % Chg.

Sales % Change due to Currency

Sales % Change due to Currency % Chg.

Key Performance Indicators

United States Revenue

United States Revenue % Chg.

United States Revenue Common Size

Europe Revenue

Europe Revenue % Chg.

Europe Revenue Common Size

Western Hemisphere ex-US Revenue

Western Hemisphere ex-US Revenue % Chg.

Western Hemisphere ex-US Revenue Common Size

Asia Pacific, Africa Revenue

Asia Pacific, Africa Revenue % Chg.

Asia Pacific, Africa Revenue Common Size

Total Revenue by Geography

Total Revenue by Geography Common Size

Total Revenue by Geography % Chg.

Revenue by Geography

Consumer Health Revenue

Consumer Health Revenue % Chg.

Consumer Health Revenue Common Size

Innovative Medicine Revenue

Innovative Medicine Revenue % Chg.

Innovative Medicine Revenue Common Size

MedTech Revenue

MedTech Revenue % Chg.

MedTech Revenue Common Size

Other Revenue

Other Revenue % Chg.

Other Revenue Common Size

Total Revenue

Total Revenue Common Size

Total Revenue % Chg.

Revenue	LTM	Dec '24	Dec '23
Consumer Health Revenue	—	—	—
Innovative Medicine Revenue	58,970	56,964	54,759
MedTech Revenue	33,179	31,857	30,400
Other Revenue	—	—	—
Total Revenue	92,149	88,821	85,159

Revenue by Geography	LTM	Dec '24	Dec '23
United States Revenue	52,761	50,302	46,444
Europe Revenue	20,858	20,212	20,410
Western Hemisphere ex-US Revenue	4,739	4,714	4,549
Asia Pacific, Africa Revenue	13,791	13,593	13,756
Total Revenue by Geography	92,149	88,821	85,159

EBT	LTM	Dec '24	Dec '23
Consumer Health Income Before Tax	—	—	—
Innovative Medicine Income Before Tax	21,217	18,919	18,246
MedTech Income Before Tax	3,984	3,740	4,669
Other EBT	6,301	-5,972	-7,853
Total EBT	31,502	16,687	15,062

Capital Expenditures	LTM	Dec '24	Dec '23
Consumer Health Capital Expenditures	—	—	—
Innovative Medicine Capital Expenditures	—	1,710	1,653
MedTech Capital Expenditures	—	2,443	2,372
Other Capital Expenditures	—	271	518
Total Capital Expenditures	4,607	4,424	4,543

Key Performance Indicators	LTM	Dec '24	Dec '23
Sales % Change due to Transactions	—	5.9	6.8
Sales % Change due to Price	—	—	0.6
Sales % Change due to Currency	—	-1.6	-0.9